Biological Drugs for the Treatment of Uncontrolled Severe Asthma in Children.
Curr Pediatr Rev
; 20(3): 265-270, 2024.
Article
en En
| MEDLINE
| ID: mdl-37702164
ABSTRACT
The introduction of biological drugs for the treatment of severe allergic asthma in children, almost twenty years ago, had a substantial impact on both the pathology's clinical course and the quality of life of the patients who receive treatment. Over the years, several molecules have been developed that inhibit molecular targets involved in the pathogenesis of the asthmatic disease. Biological drugs demonstrate a significant improvement in several key clinical parameters in patients with severe asthma. In this review, we provide a concise summary of the evidence on biological therapy for children and adolescents with severe asthma.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Asma
/
Productos Biológicos
/
Antiasmáticos
Límite:
Adolescent
/
Child
/
Humans
Idioma:
En
Revista:
Curr Pediatr Rev
Año:
2024
Tipo del documento:
Article
País de afiliación:
Italia